Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Axsome Therapeutics, Inc.
| Metric | Axsome Therapeutics, Inc. AXSMHealthcare |
|---|---|
| Quality Score | 50 / 100 |
| Revenue (latest) | $638M |
| Net income (latest) | −$183M |
| Operating margin | −26.1% |
| Net margin | −28.7% |
| Return on equity | −207.5% |
| Return on assets | −26.6% |
| Return on capital (ROCE) | −53.6% |
| Debt / equity | 6.81× |
| Revenue growth (YoY) | 65.5% |
| Altman Z″ (distress) | -5.64 |
| Accruals / assets | −13.0% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.